Meetodi tõendite kirje

Phase IV study

A Phase IV study is a post-marketing surveillance study conducted after a drug, device, or intervention has received regulatory approval. Its primary purpose is to monitor long-term safety, detect rare adverse events, assess effectiveness in routine clinical practice, and explore new indications or populations not adequately represented in earlier trials. Phase IV evidence accumulates continuously throughout a product's commercial life.

Sources recorded, not reviewed

Allikakirje

Tsiteeringud kopeeritud meetodi allikakirjest sõna-sõnalt. Nendest ei saa järeldada väidete tasemel kinnitust.

Phase IV Post-Marketing Surveillance Study

Taksonoomiline meetodikirje · process-pipeline / epidemiology

Ava täielik meetod

Kureeritud väited

Väited on salvestatud tõendite registrisse, igal oma hinnanguga.

Kureeritud väiteid veel pole

See vaade ei loo väite hinnangut, kui registris seda pole.

Seotud meetodid

Genereeritud meetodigraafist ja kuvatud masina soovitatud seostena – väiteid ei järeldata.

Taxonomic bucketCase-control studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketCohort Studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketCross-sectional epidemiological studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase III clinical trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketRandomized clinical trialmachine-suggested · Relational suggestion, not evidence.